| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2174/138161209787315729 |
| P698 | PubMed publication ID | 19199976 |
| P50 | author | Dimitri P Mikhailidis | Q62561943 |
| P2093 | author name string | Konstantinos Tziomalos | |
| Asterios Karagiannis | |||
| Vasilios G Athyros | |||
| Anna I Kakafika | |||
| P433 | issue | 5 | |
| P921 | main subject | pleiotropy | Q1134884 |
| P304 | page(s) | 479-489 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Current Pharmaceutical Design | Q5195068 |
| P1476 | title | Pleiotropic effects of statins--clinical evidence | |
| P478 | volume | 15 |
| Q36054829 | Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia |
| Q51388945 | Anti‐Inflammatory and Monocyte‐Suppressing Effects of Simvastatin in Patients with Impaired Fasting Glucose |
| Q34157133 | Applied Healthspan engineering |
| Q36392153 | Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice |
| Q37421028 | Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway |
| Q38058827 | Atorvastatin calcium plus amlodipine for the treatment of hypertension. |
| Q37765562 | Atorvastatin: safety and tolerability |
| Q33829180 | Cardiovascular benefits of bariatric surgery in morbidly obese patients |
| Q38083042 | Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review |
| Q53305102 | Combination of rosuvastatin and probucol inhibits MMP-9 expression via upregulation of miR-497 in cultured HUVECs and apoE knockout mice. |
| Q34305993 | Combination therapy of statins and fibrates in the management of cardiovascular risk |
| Q34018973 | Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study |
| Q35646020 | Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea |
| Q36796490 | Current Perspectives on rosuvastatin |
| Q37859419 | Current therapeutic strategies in non-alcoholic fatty liver disease. |
| Q33776187 | Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia? |
| Q44228351 | Effect of prior treatment with different statins on stroke severity and functional outcome at discharge in patients with acute ischemic stroke. |
| Q61445076 | Effectiveness of long-term using statins in COPD - a network meta-analysis |
| Q43083014 | Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention |
| Q38809604 | HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015). |
| Q42754391 | Hemostatic effects of simvastatin in subjects with impaired fasting glucose. |
| Q47883650 | Immobilization of R. erythropolis in alginate-based artificial cells for simulated plaque degradation in aqueous media |
| Q37923226 | Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy--evidence from clinical studies |
| Q43300344 | Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemia |
| Q36286258 | Lipid-lowering therapies and achievement of LDL-cholesterol targets |
| Q38129422 | Lipid-lowing pharmacogenomics in Chinese patients |
| Q24234141 | Low-fat diets for acquired hypercholesterolaemia |
| Q51375949 | Lymphocyte-suppressing effect of simvastatin in mixed dyslipidemic patients but not impaired glucose tolerance patients. |
| Q35678484 | Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritis |
| Q26770809 | Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart |
| Q37649834 | Neurofibromin-deficient myeloid cells are critical mediators of aneurysm formation in vivo |
| Q37826757 | Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review |
| Q36302505 | Pharmacological characterization of mechanisms involved in the vasorelaxation produced by rosuvastatin in aortic rings from rats with a cafeteria-style diet. |
| Q39015072 | Pharmacological management of diabetic dyslipidemia |
| Q38042590 | Plasma matrix metalloproteinase 9 levels may predict endoleaks after endovascular aortic aneurysm repair |
| Q90176069 | Pleiotropic Effects of Simvastatin on the Regulation of Potassium Channels in Monocytes |
| Q34153553 | Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes |
| Q37403235 | Pleiotropic vasoprotective effects of statins: the chicken or the egg? |
| Q47442080 | Predictors of abdominal aortic aneurysm (AAA) growth and AAA rupture risk besides AAA size: fact or fiction? |
| Q35622817 | Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role? |
| Q51535949 | Reduced Health Care Expenditures After Enrollment in a Collaborative Cardiac Care Service |
| Q42330281 | Role of lipid-lowering agents in the management of diabetic retinopathy |
| Q42791977 | Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis |
| Q35674320 | Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study |
| Q38541832 | Safety considerations with fenofibrate/simvastatin combination. |
| Q50595331 | Serum leptin levels in patients undergoing carotid endarterectomy: a pilot study. |
| Q53586234 | Simulation and verification of macroscopic isotropy of hollow alginate-based microfibers. |
| Q48112952 | Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study |
| Q38274960 | Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis. |
| Q30943920 | Statin-associated ocular disorders: the FDA and ADRAC data |
| Q38599323 | Statins and their increased risk of inducing diabetes |
| Q41307995 | Statins may be beneficial for patients with pulmonary hypertension secondary to lung diseases |
| Q42792235 | The Effect of Simvastatin on Lymphocyte Secretory Function in Patients With Impaired Fasting Glucose |
| Q64993551 | The Role of Statins in the Management of Patients Undergoing Coronary Artery Bypass Grafting. |
| Q46668688 | The effect of ezetimibe on androgen production in hypercholesterolemic women with polycystic ovary syndrome. |
| Q39183197 | The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review |
| Q38742876 | The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia |
| Q42854439 | To switch (statins) or not to switch? That is the question |
| Q38204182 | Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins? |
Search more.